Diagnostic Kits/Commons based cases in Kits: Difference between revisions
Jump to navigation
Jump to search
| Line 20: | Line 20: | ||
** We could touch base with the BBF to find out of there are any publications in preparation or an expert who could provide more information in an interview by subscribing to and emailing legal@biobricks.org. If that doesn't work, contacting someone from the recent BBF + Berkeley Law Samuelson Clinic would probably be effective. | ** We could touch base with the BBF to find out of there are any publications in preparation or an expert who could provide more information in an interview by subscribing to and emailing legal@biobricks.org. If that doesn't work, contacting someone from the recent BBF + Berkeley Law Samuelson Clinic would probably be effective. | ||
** Example set of parts: http://partsregistry.org | ** Example set of parts: http://partsregistry.org | ||
** Janet Hope covers the BBF & CAMBIA in her book, Biobazaar, on pages 316-317: [http://evernote.com/pub/macowell/icp#Note/7f91feeb-c700-46f2-a68e-3dfa96c4a5c4 here's a scan] | ** Janet Hope covers the BBF & CAMBIA in her book, Biobazaar, on pages 316-317: [http://evernote.com/pub/macowell/icp#Note/7f91feeb-c700-46f2-a68e-3dfa96c4a5c4 here's a scan] ([http://books.google.com/books?id=IPTwYNqpJWgC&pg=PA250&dq=janet+hope+biobazaar+biobricks&ei=oZihSqnIHY7ayASMjMWPCA#v=onepage&q=biobricks&f=false and here's a google book search]) | ||
==Navigation== | ==Navigation== | ||
Revision as of 17:46, 4 September 2009
Answer the questions:
- Commons based cases (the cases that we know will appear in the right part of the quadrants)
- Identify cases
- Correlate them with their main outputs (Data. Narratives. Tools)
- How and in what extent they are “experimenting” or “adopting” commons-based approach. Are they adopting OA policies, for instance? Are they adopting Social Responsible License approaches?
- Identify these cases and treat them as entities that will also be placed in our mapping device (the quadrants)
- Identify what actors are participating on this and what actors are just observers (Use the questionnaire to guide your research when appropriate - Carol will select specific relevant and helpful questions)
- The Biological Innovation for Open Society (BIOS) license
- This specifically aims to provide open access to patented DNA sequences.
- Resources:
- Wired Magazine [[1]]
- Geertrui Van Overwalle et al., 2005. Models for facilitating access to patents on genetic inventions. Available at: http://www.nature.com/nrg/journal/v7/n2/full/nrg1765.html [Accessed August 10, 2009].
- BiOS site [[2]]
- The proposed BioBricks Foundation (BBF) license for BioBrick-standard biological "parts"
- More information here: http://openwetware.org/wiki/The_BioBricks_Foundation:Legal
- Drew Endy from the BBF has been increasingly focused on developing the license, organizing legal workshops and spending more time talking about it in lectures, but I couldn't find much online describing progress the BBF has made recently (they have been spending significant time working on it for at least the last 12 months).
- We could touch base with the BBF to find out of there are any publications in preparation or an expert who could provide more information in an interview by subscribing to and emailing legal@biobricks.org. If that doesn't work, contacting someone from the recent BBF + Berkeley Law Samuelson Clinic would probably be effective.
- Example set of parts: http://partsregistry.org
- Janet Hope covers the BBF & CAMBIA in her book, Biobazaar, on pages 316-317: here's a scan (and here's a google book search)